Omnipod 5 System Compared to Pump Therapy

NACompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

July 7, 2022

Primary Completion Date

September 14, 2023

Study Completion Date

January 10, 2025

Conditions
Type 1 Diabetes
Interventions
DEVICE

Omnipod 5 System

Omnipod 5 System automates insulin delivery based on information received from the continuous glucose monitoring system every 5 minutes.

Trial Locations (14)

13244

State University of New York, Upstate Medical University, Syracuse

22903

University of Virginia, Charlottesville

30318

Atlanta Diabetes, Atlanta

60208

Northwestern University, Evanston

78229

Diabetes & Glandular Disease Clinic, P.A. (DGD Clinic), San Antonio

80045

University of Colorado Denver, Denver

93105

Sansum Diabetes Research Institute, Santa Barbara

94304

Stanford University School of Medicine, Palo Alto

98109

University of Washington, Seattle

02215

Joslin Diabetes Center, Boston

Unknown

Hopital Sud-Francilien, Corbeil-Essonnes

Hospices Civils de Lyon - Centre du diabete Diab-eCare, Lyon

CHRU de Montpellier, Hopital Lapeyronie - Departement d'endocrinologie, Diabete, Nutrition, Montpellier

Hopital Lariboisiere - Centre Universitaire du Diabete et de ses Complications, Paris

Sponsors
All Listed Sponsors
lead

Insulet Corporation

INDUSTRY

NCT05409131 - Omnipod 5 System Compared to Pump Therapy | Biotech Hunter | Biotech Hunter